Protagenic Therapeutics, Inc.\new (PTIX)
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Protagenic Therapeutics, Inc.
OTC:PTIXHealthcare · Biotechnology
-10.02%$0.6478
Mkt Cap$1.17M
Float1.25M
O/S1.81M
Inst Own3.7%
SI1.0%
Dilution
MCap$1.17M
Float1.25M
O/S1.81M
Dilution